Publications

During the annual Recognition Ceremony, the Morningside Graduate School of Biomedical Sciences celebrated 74 PhD candidates and MD/PhD students who successfully completed their qualifying exam in 2024-2025.

UMass Chan Medical licenses exNA oligonucleotide technology to Hongene Biotech Corporation

The Morningside Graduate School of Biomedical Sciences at UMass Chan Medical School honored student scientists for outstanding research and leadership qualities on May 29.

A siRNA therapeutic for dermatological diseases developed at UMass Chan Medical School has entered the clinical trial phase.

Anastasia Khvorova, PhD, has been awarded the 2025 Else Kröner Fresenius Prize for Medical Research.

A biochemical breakthrough using simple carbon atoms by Ken Yamada, PhD, and Anastasia Khvorova, PhD, has dramatically improved the stability and efficacy of a potential oligonucleotide therapeutic platform in mice.

Natick resident and Stanford Online High School student Rebecca Ahn outperformed other local high school students in the final round of the competition on March 16.

Representatives from UMass Chan presented on several topics and career paths, including RNA Therapeutics Institute, ScienceLive, community and government relations, diversity and inclusion and media and arts in sciences.

A new RNA therapeutic for preeclampsia is based on work by UMass Chan researchers and collaborating scientists. Researchers explain the importance of a multipronged approach to addressing factors underlying health disparities in this Science for Living article.

MD/PhD student Jillian Belgrad has received an award from the National Institute of Neurological Disorders and Stroke to study the pathology that drives the development of Huntington’s disease symptoms.  

News from the Anastasia Khvorova Lab at UMass Chan Medical School

Chancellor Collins to UMass Chan PhD candidates: ‘We need your science’

UMass Chan Medical School licenses exNA oligonucleotide technology to Hongene Biotech Corporation

Morningside Graduate School of Biomedical Sciences honors students during annual awards ceremony

Clinical trial participant receives first dose of UMass Chan-developed treatment for alopecia areata by Alys Pharmaceuticals

Anastasia Khvorova receives 2025 Else Kröner Fresenius Prize for Medical Research

Novel siRNA backbone developed at UMass Chan enhances stability, durability of potentially therapeutic platform

Local high school students compete in Central Mass. Brain Bee at UMass Chan

UMass Chan helps ‘Crack the Code’ at biotech career day in Worcester

Science for Living: Understanding preeclampsia, its toll on Black women and a promising therapeutic on the way

MD/PhD student using NIH award to study onset of Huntington’s disease